170 related articles for article (PubMed ID: 16857348)
1. Continuous versus intermittent levofloxacin treatment in complicated urinary tract infections caused by urinary obstruction temporarily relieved by foreign body insertion.
Tenke P; Kovacs B; Benkõ R; Ashaber D; Nagy E
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S82-5. PubMed ID: 16857348
[TBL] [Abstract][Full Text] [Related]
2. [Antibiotics in urinary tract infections. One quinolone for 3 days].
MMW Fortschr Med; 2001 Oct; 143(40):57. PubMed ID: 11692853
[No Abstract] [Full Text] [Related]
3. [Efficacy of a single-day administration of levofloxacin for the prevention of urinary tract infections after urogenital examinations and treatments for outpatients].
Hayashi T; Sakai Y; Saito K; Arai G; Hyochi N; Suzuki M; Masuda H; Kawakami S; Okuno T; Kobayashi T; Kageyama Y; Kihara K
Hinyokika Kiyo; 2001 Nov; 47(11):773-5. PubMed ID: 11771168
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of levofloxacin (Tavanik, "Aventis Pharma") in the treatment of complicated infections of the urogenital organs].
Derevianko II; Lavrinova LN; Kudriashova EE
Urologiia; 2003; (1):31-4. PubMed ID: 12621964
[No Abstract] [Full Text] [Related]
5. [Oral antibiotic treatment of urinary tract infections in children].
Klingenberg C; Småbrekke L; Døllner H; Simonsen GS
Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1342-4. PubMed ID: 19561661
[TBL] [Abstract][Full Text] [Related]
6. [Uroinfections and the possibilities of therapy with levofloxacin].
Slavov Ch; Markova B; Bovianska N; Proevska Iu; Chukov I; Panchev P
Khirurgiia (Sofiia); 2004; 60(4-5):22-5. PubMed ID: 16042059
[TBL] [Abstract][Full Text] [Related]
7. [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
Trinchieri A; Marchetti F
Arch Ital Urol Androl; 2003 Mar; 75(1):49-52. PubMed ID: 12741347
[TBL] [Abstract][Full Text] [Related]
8. [Faropenem 300 mg 3 times daily versus levofloxacin 100 mg 3 times daily in the treatment of urinary tract infections in patients with neurogenic bladder and/or benign prostatic hypertrophy].
Muratani T; Iihara K; Nishimura T; Inatomi H; Fujimoto N; Kobayashi T; Yamada Y; Takahashi K; Matsumoto T
Kansenshogaku Zasshi; 2002 Nov; 76(11):928-38. PubMed ID: 12508476
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study of ofloxacin in complicated urinary tract infection].
Akazawa N; Tsugawa M; Hayata S; Sasaki H; Asahi T; Okita K
Hinyokika Kiyo; 1988 Jul; 34(7):1279-82. PubMed ID: 3177148
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of peri-operative infection with levofloxacin in female patients undergoing surgery for stress urinary incontinence].
Cao DY; Zhu L; Wang JH; Zhang Y
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1485-7. PubMed ID: 18953856
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance in children with recurrent or complicated urinary tract infection.
Younis N; Quol K; Al-Momani T; Al-Awaisheh F; Al-Kayed D
JNMA J Nepal Med Assoc; 2009; 48(173):14-9. PubMed ID: 19529052
[TBL] [Abstract][Full Text] [Related]
12. Single dose of ofloxacin treatment in women with dysuria and frequency.
Simşek F; Dillioğlugil O; Ilker Y; Akdaş A
Int Urol Nephrol; 1993; 25(3):249-54. PubMed ID: 8225825
[TBL] [Abstract][Full Text] [Related]
13. Regional community-acquired urinary tract infections in Israel: diagnosis, pathogens, and antibiotic guidelines adherence: a prospective study.
Nesher L; Novack V; Riesenberg K; Schlaeffer F
Int J Infect Dis; 2007 May; 11(3):245-50. PubMed ID: 16891141
[TBL] [Abstract][Full Text] [Related]
14. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
Schumm K; Lam TB
Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
[TBL] [Abstract][Full Text] [Related]
16. Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation.
Reid G; Habash M; Vachon D; Denstedt J; Riddell J; Beheshti M
Int J Antimicrob Agents; 2001 Apr; 17(4):317-9; discussion 319-20. PubMed ID: 11295415
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care.
McNulty CA; Richards J; Livermore DM; Little P; Charlett A; Freeman E; Harvey I; Thomas M
J Antimicrob Chemother; 2006 Nov; 58(5):1000-8. PubMed ID: 16998209
[TBL] [Abstract][Full Text] [Related]
18. Urinary tract infection in the renal transplant patient.
de Souza RM; Olsburgh J
Nat Clin Pract Nephrol; 2008 May; 4(5):252-64. PubMed ID: 18334970
[TBL] [Abstract][Full Text] [Related]
19. Corynebacterium urealyticum urinary tract infection in a cat with urethral obstruction.
Cavana P; Zanatta R; Nebbia P; Miniscalco B; Vittone V; Zanoni MG; Serra R; Farca AM
J Feline Med Surg; 2008 Jul; 10(3):269-73. PubMed ID: 18243748
[TBL] [Abstract][Full Text] [Related]
20. An open, non comparative study of ofloxacin i.v. on the treatment of acute symptomatic urinary tract infection.
Asvanich K; Fugpholngam V; Srimuang S; Tanphaichitra D
J Med Assoc Thai; 2000 Jul; 83(7):771-5. PubMed ID: 10932512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
